TYVASO (United Therapeutics Corp.)


Welcome to the PulseAid listing for the TYVASO drug offered from United Therapeutics Corp.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: United Therapeutics Corp.
NON-PROPRIETARY NAME: treprostinil
SUBSTANCE NAME: TREPROSTINIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: ORAL
DOSAGE FORM: INHALANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-14
END MARKETING DATE: 0000-00-00


TYVASO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTYVASO from United Therapeutics Corp.
LABELER NAME: United Therapeutics Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.74(mg/2.9mL)
START MARKETING DATE: 2009-08-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66302-206_48a56429-cb1f-4659-ac4b-c2bb1e5316c1
PRODUCT NDC: 66302-206
APPLICATION NUMBER: NDA022387

Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalOrenitram
United Therapeutics Corp.TYVASO
United Therapeutics CorporationRemodulin